Alan Joslyn
CIK 1294887 · CEO and President · last filed 2021-02-19
Alan Joslyn is a CEO and President who has filed 20 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for OGEN, was dated Feb 19, 2021. Across all open-market trades the lifetime net is −$99.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $41.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$41.3K
3
20
-$99.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | CEO and President | 66,667 | $0.62 | $41.3K | $0 | 8 | 2021-02-19 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Director | — | — | — | $0 | 2 | 2018-06-19 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Director | 13,254 | — | — | -$99.3K | 10 | 2016-06-29 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-19 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | OGEN | E | — | $0 | EDGAR |
| 2020-02-07 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2019-03-27 | OGEN | Buy (P) | +66,667 | $0 | EDGAR |
| 2018-10-01 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2018-06-26 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2018-06-19 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-30 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Mixed | — | $0 | EDGAR |
| 2017-06-26 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2016-06-29 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |